Where to Inject Semaglutide: A Comprehensive Guide

Last reviewed: May 14, 2026

Last updated: May 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide injections are administered subcutaneously in specific anatomical areas: the abdomen, thigh, or upper arm. Proper site selection and rotation reduce tissue damage, improve medication absorption, and support consistent therapeutic outcomes across your treatment course.

Beyond technique, individual genetic factors in GLP-1 receptor pathways and metabolic biomarkers may influence how your body responds to this therapy. PlexusDx helps patients understand their genetic context so they can have more informed conversations with their providers about personalized treatment planning.

Approved Subcutaneous Injection Sites for Semaglutide

The abdomen, outer thigh, and upper arm are the three approved injection sites for subcutaneous semaglutide. Each location has distinct advantages: the abdomen offers ease of access and consistent absorption; the thigh and upper arm provide alternatives for patients with body composition considerations or comfort preferences.

Clinical guidance emphasizes rotating injection sites within the same anatomical region week to week, then rotating between regions monthly. This strategy minimizes lipohypertrophy (fatty tissue buildup), reduces injection-site reactions, and helps maintain steady medication absorption over time.

Injection Site Anatomy and Absorption Patterns

Subcutaneous tissue depth and blood flow vary across injection sites. The abdomen typically has deeper subcutaneous tissue and faster absorption kinetics; the thigh and upper arm may exhibit slower, more variable absorption depending on muscle mass and regional perfusion.

Injection Site	Tissue Depth	Absorption Speed	Practical Considerations
Abdomen (2 inches from navel)	5–15 mm	Fastest/most consistent	Easiest access; avoid scars; good for weekly routine
Outer Thigh	8–12 mm	Moderate; variable by muscle mass	Convenient for self-injection; less consistent in athletes
Upper Arm (outer surface)	6–10 mm	Moderate to slow	Requires mirror or assistance; useful for rotation strategy
Lipohypertrophy Risk	All sites if rotated poorly	Impaired absorption if present	Rotate sites every 7 days within region; change regions monthly

Best Practices for Safe and Effective Injection Technique

Proper technique includes pinching the skin to lift subcutaneous tissue, inserting the needle at a 90-degree angle, injecting slowly over 5–10 seconds, and withdrawing the needle at the same angle. Room-temperature medication reduces injection discomfort. Hand hygiene and non-touch aseptic technique are essential to prevent infection.

Document each injection site in a simple log or app to ensure systematic rotation and prevent repeated use of the same spot. Many patients benefit from visual guides or provider consultations to confirm proper needle depth and angle, especially during the first injection.

Who Should Use Semaglutide and When to Consult Your Provider

Semaglutide is approved for adults with type 2 diabetes or chronic weight management when BMI is ≥30 or ≥27 with weight-related conditions. It is not recommended in pregnancy, personal history of medullary thyroid carcinoma, or multiple endocrine neoplasia type 2. A qualified healthcare provider must assess your medical history and baseline metabolic status.

Before starting, inform your provider of gastroparesis history, recent pancreatitis, kidney or liver disease, or concurrent GLP-1 receptor agonist use. Proper injection technique and site rotation are medical skills that your provider or a nurse can teach during your first administration visit.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your individual predispositions in key GLP-1 receptor and metabolic pathways, including variants like GLP1R rs6923761. This information does not predict exact medication response but can support a more informed discussion with your provider about whether semaglutide aligns with your genetic and biomarker profile.

The test reveals genetic predispositions related to GLP-1 receptor sensitivity, insulin secretion, and appetite regulation. Understanding these pathways should be interpreted with a qualified healthcare provider to inform personalized treatment planning, dosing considerations, and monitoring strategy alongside clinical findings.

Combined with proper injection technique and anatomical knowledge, genetic and biomarker context may help you and your provider optimize your semaglutide regimen. This multi-layered approach supports safer administration, better therapeutic alignment, and more personalized care.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same spot every week?

No. Repeated injections at the same site increase lipohypertrophy risk, which can impair medication absorption. Rotate within the same anatomical region weekly, then switch regions monthly for optimal outcomes.

What is lipohypertrophy and how does it affect semaglutide absorption?

Lipohypertrophy is fatty tissue buildup at injection sites. It reduces subcutaneous blood flow and slows medication absorption, potentially compromising therapeutic efficacy. Systematic site rotation prevents this complication.

How much does compounded semaglutide cost at PlexusDx?

PlexusDx compounded semaglutide injection ranges from $149 per month from licensed 503A pharmacies. Pricing varies by dose and formulation. Visit our semaglutide injection product page for current options and consultation details.

What should I do if I experience redness or pain at the injection site?

Minor redness or mild discomfort typically resolves within hours. If redness persists beyond 48 hours, swelling increases, or warmth or drainage develops, contact your provider immediately to rule out infection or allergic reaction.

How can the Precision Peptide Genetic Test help me prepare for semaglutide therapy?

The test reveals predispositions in GLP-1 receptor and metabolic pathways that may inform your provider's assessment of treatment suitability. This genetic context, combined with injection technique and biomarker monitoring, supports more personalized therapy planning.